Company news
BioLineRX Ltd. news in 2026
BioLineRX Ltd.'s news releases, calls and decks from 2026, newest first.
BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026)
September 10, 2026
BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026
BioLineRx to Report First Quarter 2026 Results on May 27, 2026
May 20, 2026
BioLineRx and Hemispherian Announce First Patient Dosed in Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
April 28, 2026
Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma
April 8, 2026
BioLineRx Announces Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
March 26, 2026
BioLineRx Reports 2025 Financial Results and Provides Corporate Update
March 23, 2026
BioLineRx to Report 2025 Annual Results on March 23, 2026
March 16, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (July 2026)
Investor deck · 39 slides · July 2026
- Q1 2026 Earnings Presentation
Earnings · 28 slides · May 27, 2026